Clomid triggers ovulation in roughly 80% of women who take it, making it one of the most reliable first-line fertility medications available. But ovulation and pregnancy are two different things. Only about half of women who ovulate on Clomid actually become pregnant, and per-cycle pregnancy rates sit around 10 to 15%. Understanding the gap between those numbers is key to setting realistic expectations.
Ovulation Rates vs. Pregnancy Rates
Clomid works by blocking estrogen receptors in the brain, which tricks the body into producing more of the hormones that stimulate the ovaries. The result is that most women who weren’t ovulating on their own will start releasing eggs. About 75 to 80% of women ovulate at some dosage level, typically starting at 50 mg daily and increasing to 100 mg or 150 mg if the lower dose doesn’t work.
The pregnancy rate per cycle, however, is considerably lower. When Clomid is paired with intrauterine insemination (IUI), each cycle carries roughly a 10 to 15% chance of pregnancy. Over three well-timed cycles, cumulative success reaches approximately 25 to 40%, depending on age and the underlying cause of infertility. A large randomized trial of 900 couples with unexplained infertility found a 23.3% live birth rate after up to four cycles of Clomid with IUI.
Why the gap between ovulation and pregnancy? Releasing an egg is only one step. The sperm still has to reach it, fertilization has to occur, the embryo has to implant, and the pregnancy has to sustain itself. Clomid solves the ovulation problem but doesn’t address those other factors.
Why It Works Better for PCOS
Clomid is most effective when the primary issue is irregular or absent ovulation, which is why it’s considered a go-to treatment for polycystic ovary syndrome (PCOS). Women under 35 with PCOS who ovulate on Clomid have about a 15% chance of pregnancy per month, assuming normal sperm quality and open fallopian tubes. That’s close to the natural conception rate for fertile couples of the same age.
For unexplained infertility, the picture is murkier. One trial of 201 couples found that Clomid with IUI produced a 31% live birth rate over three cycles, compared to just 9% with no treatment. But other studies, including a systematic review, found no significant difference in live births between Clomid and expectant management for this group. The inconsistency likely reflects how broad the “unexplained” category is. Some of those couples have subtle issues Clomid can’t fix.
The Thin Lining Problem
One of Clomid’s trade-offs is its effect on the uterine lining. While it blocks estrogen receptors in the brain to boost ovulation, it also blocks estrogen in the uterus. This can make the endometrial lining thinner than ideal, which matters because embryos need a sufficiently thick lining to implant successfully. Research published in Frontiers in Endocrinology found that Clomid produces a uterine lining about 1.7 mm thinner on average than injectable fertility medications do, and thinner lining was associated with lower pregnancy rates in Clomid cycles specifically.
This anti-estrogenic effect helps explain why ovulation rates are high but pregnancy rates lag behind. It also explains why some doctors prefer letrozole for certain patients, since it doesn’t carry the same lining-thinning property.
When Clomid Doesn’t Work
About 20% of women don’t ovulate even at the maximum dose of 150 mg daily for at least three cycles. This is called Clomid resistance, and it’s most common in women with PCOS who have higher body weight or more severe hormonal imbalances. Increasing the dose beyond 150 mg to 200 mg produces very few additional pregnancies.
Even among women who do ovulate, current guidelines recommend moving on after six ovulatory cycles without conception. At that point, the odds of Clomid working in a subsequent cycle drop substantially, and the persistent estrogen-blocking effects on the uterine lining may be doing more harm than good. Options after Clomid typically include injectable fertility medications, IVF, or in the case of PCOS, a minor surgical procedure on the ovaries.
How Age Changes the Odds
Age is the single biggest factor in whether Clomid leads to a baby. The medication can make you ovulate, but it can’t improve egg quality, which declines steadily after the early 30s and drops more sharply after 37. A 28-year-old with PCOS who ovulates on Clomid has meaningfully better odds than a 39-year-old in the same situation, even if both are releasing eggs on schedule. This is why fertility specialists often recommend moving to more aggressive treatments sooner for women in their late 30s rather than spending months on Clomid.
Twin and Multiple Pregnancy Risk
Clomid increases the chance of twins because it can cause the ovaries to release more than one egg per cycle. The twin rate with Clomid runs between 5.7% and 11.7% of pregnancies, compared to about 0.3% with natural conception. That’s roughly 7 to 10 times the baseline risk. Triplets occur in about 0.4% of Clomid pregnancies. Higher-order multiples (quadruplets or more) are rare with Clomid, especially compared to injectable fertility medications, which carry a substantially higher multiple pregnancy risk.
What a Typical Clomid Cycle Looks Like
Most women start at 50 mg daily, taken for five consecutive days early in the menstrual cycle. If that dose doesn’t trigger ovulation, the next cycle uses 100 mg, and occasionally 150 mg after that. Your doctor will typically monitor the response with ultrasound or blood work to confirm that eggs are developing and to time intercourse or insemination.
The medication itself is a pill, which makes it simpler and far less expensive than injectable alternatives. Side effects can include hot flashes, mood changes, bloating, and headaches, but most women tolerate it well. Visual disturbances like blurred vision are less common but should be reported promptly, as they typically mean the medication needs to be stopped.
The realistic timeline is three to six cycles. If you’re ovulating on Clomid but not pregnant after that window, additional testing or a different treatment approach is the standard next step.